Enhanced oxidative burst without interleukin 1 production by normal human polymorphonuclear leukocytes primed with muramyl dipeptides
Related Experiment Videos
Abstract:
Purified polymorphonuclear (PMN) cells were obtained from human blood leukocytes by centrifugation on colloidal silica gradients. PMNs could be primed for PMA-triggered oxidative burst by muramyl peptide molecules (MDP) and two of its adjuvant active nonpyrogenic derivatives. The priming effect of MDP could be demonstrated after a 1-h incubation period, whereas monocytes needed an 18-h incubation to produce an enhanced response in the NBT reduction test. Only the monocyte-enriched population was able to produce IL-1 activity after muramyl peptide stimulation. Under such conditions, PMNs neither produced nor secreted IL-1-like activity, and no IL-1 inhibitor was present in the supernatant fluids. In conclusion, muramyl peptides were able to prime PMNs for oxidative burst but not to stimulate IL-1-like factor production.
Insights
Muramyl peptides prime polymorphonuclear (PMN) cells for oxidative burst but do not stimulate interleukin-1 (IL-1) production. Monocytes, however, require longer incubation to respond to muramyl peptides for enhanced NBT reduction and IL-1 activity.
Area of Science:
- Immunology
- Cell Biology
Background:
- Polymorphonuclear cells (PMNs) and monocytes are key immune cells involved in host defense.
- Muramyl peptides (MDP) are known immunomodulators with adjuvant properties.
- Understanding the differential response of immune cells to MDP is crucial for developing novel immunotherapies.
Purpose of the Study:
- To investigate the effects of muramyl peptides (MDP) on polymorphonuclear (PMN) cells and monocytes.
- To compare the ability of MDP to stimulate oxidative burst and IL-1 production in PMNs and monocytes.
- To determine the time course of MDP-induced responses in these immune cells.
Main Methods:
- Human blood leukocytes were purified to obtain polymorphonuclear (PMN) cells using colloidal silica gradients.
- PMNs and monocyte-enriched populations were incubated with MDP and its derivatives.
- The nitroblue tetrazolium (NBT) reduction test was used to assess oxidative burst.
- Interleukin-1 (IL-1) activity in cell supernatants was measured.
Main Results:
- MDP primed PMNs for PMA-triggered oxidative burst within 1 hour.
- Monocytes required an 18-hour incubation period to show enhanced NBT reduction in response to MDP.
- Only the monocyte-enriched population produced IL-1 activity after MDP stimulation; PMNs did not.
- No IL-1 inhibitor was detected in the supernatant fluids of stimulated PMNs.
Conclusions:
- Muramyl peptides (MDP) effectively prime PMNs for enhanced oxidative burst.
- MDP does not stimulate IL-1-like factor production or secretion in PMNs.
- Monocytes exhibit a delayed but enhanced response to MDP, including IL-1 production.